Folate Receptor–Targeted Single-Photon Emission Computed Tomography/Computed Tomography to Detect Activated Macrophages in Atherosclerosis: Can It Distinguish Vulnerable from Stable Atherosclerotic Plaques?
暂无分享,去创建一个
Kim Van der Heiden | Marion de Jong | Jolanda J Wentzel | Antonius F W van der Steen | Cristina Müller | A. V. D. van der Steen | J. Wentzel | M. de Jong | B. V. van Thiel | H. Groen | K. van der Heiden | C. Müller | Leah C J Winkel | Harald C Groen | Bibi S van Thiel | L. Winkel | Bibi S. van Thiel
[1] P. Low,et al. Imaging of Atherosclerosis in Apoliprotein E Knockout Mice: Targeting of a Folate-Conjugated Radiopharmaceutical to Activated Macrophages , 2010, Journal of Nuclear Medicine.
[2] H. Weinans,et al. Imaging of activated macrophages in experimental osteoarthritis using folate-targeted animal single-photon-emission computed tomography/computed tomography. , 2011, Arthritis and rheumatism.
[3] M. Bijl,et al. Macrophage folate receptor-β (FR-β) expression in auto-immune inflammatory rheumatic diseases: a forthcoming marker for cardiovascular risk? , 2012, Autoimmunity reviews.
[4] R. Krams,et al. Fibromodulin Deficiency Reduces Low-Density Lipoprotein Accumulation in Atherosclerotic Plaques in Apolipoprotein E–Null Mice , 2013, Arteriosclerosis, thrombosis, and vascular biology.
[5] R. Schibli,et al. Tumor targeting using 67Ga-DOTA-Bz-folate--investigations of methods to improve the tissue distribution of radiofolates. , 2011, Nuclear medicine and biology.
[6] F. Grosveld,et al. Atherosclerotic Lesion Size and Vulnerability Are Determined by Patterns of Fluid Shear Stress , 2006, Circulation.
[7] R. Schibli,et al. DOTA Conjugate with an Albumin-Binding Entity Enables the First Folic Acid–Targeted 177Lu-Radionuclide Tumor Therapy in Mice , 2013, The Journal of Nuclear Medicine.
[8] R. Krams,et al. Contrast enhancement by differently sized paramagnetic MRI contrast agents in mice with two phenotypes of atherosclerotic plaque. , 2011, Contrast media & molecular imaging.
[9] Patrick W Serruys,et al. Shear stress-induced changes in atherosclerotic plaque composition are modulated by chemokines. , 2007, The Journal of clinical investigation.
[10] J. Wentzel,et al. Transglutaminase activity regulates atherosclerotic plaque composition at locations exposed to oscillatory shear stress. , 2012, Atherosclerosis.
[11] R. Schibli,et al. In vitro and in vivo evaluation of an innocuous drug cocktail to improve the quality of folic acid targeted nuclear imaging in preclinical research. , 2013, Molecular pharmaceutics.
[12] Marion de Jong,et al. SPECT Study of Folate Receptor-Positive Malignant and Normal Tissues in Mice Using a Novel 99mTc-Radiofolate , 2008, Journal of Nuclear Medicine.
[13] Philip S Low,et al. Folate receptor-mediated targeting of therapeutic and imaging agents to activated macrophages in rheumatoid arthritis. , 2004, Advanced drug delivery reviews.
[14] M. D. de Winther,et al. Differentiation factors and cytokines in the atherosclerotic plaque micro-environment as a trigger for macrophage polarisation , 2011, Thrombosis and Haemostasis.
[15] R. Krams,et al. Activation of MMP8 and MMP13 by angiotensin II correlates to severe intra-plaque hemorrhages and collagen breakdown in atherosclerotic lesions with a vulnerable phenotype. , 2009, Atherosclerosis.
[16] R. Krams,et al. Atherosclerotic Plaque Stability Is Affected by the Chemokine CXCL10 in Both Mice and Humans , 2011, International journal of inflammation.
[17] G. V. van Dam,et al. Targeted Folate Receptor β Fluorescence Imaging as a Measure of Inflammation to Estimate Vulnerability Within Human Atherosclerotic Carotid Plaque , 2012, The Journal of Nuclear Medicine.